HALO - Halozyme Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts9799
Avg. Estimate0.58-0.170.18-0.66
Low Estimate0.46-0.250.06-1.07
High Estimate0.66-0.130.28-0.24
Year Ago EPS-0.21-0.26-0.810.18
Revenue EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts8588
Avg. Estimate149.4M38.56M276.56M173.86M
Low Estimate141.9M34M269M144.1M
High Estimate160.3M44.4M288.4M203.4M
Year Ago Sales39M29.57M146.69M276.56M
Sales Growth (year/est)283.00%30.40%88.50%-37.10%
Earnings History12/30/20163/30/20176/29/20179/29/2017
EPS Est.-0.28-0.25-0.24-0.1
EPS Actual-0.21-0.26-0.230.02
Difference0.07-0.010.010.12
Surprise %25.00%-4.00%4.20%120.00%
EPS TrendCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Current Estimate0.58-0.170.18-0.66
7 Days Ago0.34-0.2-0.14-0.76
30 Days Ago0.27-0.21-0.13-0.79
60 Days Ago0.2-0.2-0.22-0.78
90 Days Ago-0.24-0.2-0.97-0.8
EPS RevisionsCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Up Last 7 Days7395
Up Last 30 Days7498
Down Last 30 Days2N/AN/AN/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesHALOIndustrySectorS&P 500
Current Qtr.376.20%N/AN/A0.26
Next Qtr.34.60%N/AN/A0.27
Current Year122.20%N/AN/A0.08
Next Year-466.70%N/AN/A0.12
Next 5 Years (per annum)55.00%N/AN/A0.11
Past 5 Years (per annum)N/AN/AN/AN/A